# Dominik Steubl

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dominik-steubl/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,370 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 29 |
| i10-index | 53 |
| Last Known Institution | Boehringer Ingelheim (Germany) |
| OpenAlex ID | https://openalex.org/A5053921955 |
| ORCID iD | 0000-0002-7783-8560 |
| Works | 114 |

## Researcher papers

- [Transcriptional regulation at a HTR1A polymorphism associated with mental illness](https://scholariq.org/papers/transcriptional-regulation-at-a-htr1a-polymorphism-associated-with-mental/)
- [Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients](https://scholariq.org/papers/plasma-uromodulin-correlates-with-kidney-function-and-identifies-early-stages-in/)
- [Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure](https://scholariq.org/papers/interplay-of-mineralocorticoid-receptor-antagonists-and-empagliflozin-in-heart/)
- [Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial](https://scholariq.org/papers/impact-of-primary-kidney-disease-on-the-effects-of-empagliflozin-in-patients/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [Comparison of a pocket-size ultrasound device with a premium ultrasound machine: diagnostic value and time required in bedside ultrasound examination](https://scholariq.org/papers/comparison-of-a-pocket-size-ultrasound-device-with-a-premium-ultrasound-machine/)
- [Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the <scp>EMPA‐REG OUTCOME</scp> trial](https://scholariq.org/papers/empagliflozin-and-uric-acid-metabolism-in-diabetes-a-post-hoc-analysis-of-the/)
- [Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction](https://scholariq.org/papers/mineralocorticoid-receptor-antagonists-and-empagliflozin-in-patients-with-heart/)
- [Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients](https://scholariq.org/papers/serum-calcification-propensity-and-fetuin-a-biomarkers-of-cardiovascular-disease/)
- [Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations](https://scholariq.org/papers/genetic-and-clinical-predictors-of-age-of-eskd-in-individuals-with-autosomal/)
- [Health Care Costs Associated with the Development and Combination of Cardio-Renal-Metabolic Diseases](https://scholariq.org/papers/health-care-costs-associated-with-the-development-and-combination-of-cardio/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Kidney Stones and Urolithiasis Treatments](https://scholariq.org/topics/kidney-stones-and-urolithiasis-treatments/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

## Researcher university

- [Boehringer Ingelheim (Germany)](https://scholariq.org/institutions/boehringer-ingelheim-germany/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.